The choice between a stock formula and a custom formula is the single biggest strategic decision in your private label peptide cream launch, and it has downstream effects on cost, timeline, defensibility, and regulatory readiness.
A stock formula (also called a white-label or off-the-shelf formula) is a finished, stability-tested formulation that a manufacturer has developed independently and offers to multiple brands simultaneously. You typically add your label, your fragrance choice (if options are offered), and sometimes select your peptide concentration from a menu of available variants. The advantages are substantial: 4–8 week lead times, no R&D fee, stability and challenge testing already complete, lower MOQs (often 100–300 units), and lower unit costs. The disadvantage is that your formula is not exclusive — another brand could be selling the same base under a different label. For first launches and market validation, stock formulas are almost always the right choice.
A semi-custom formula starts with the manufacturer's existing base and incorporates your specified actives, adjusts the texture or fragrance profile, or modifies the preservative system. This gives you a degree of differentiation without the full cost of bespoke development. Stability testing must be re-run (or at minimum confirmed) after any formula modification, adding 8–12 weeks and $500–$2,500 in testing costs. MOQs typically start at 300–500 units. This is the sweet spot for a brand that has validated market demand on a stock formula and wants to differentiate for a Series A or retail pitch.
A fully custom formula is developed from scratch by a cosmetic chemist to your exact specification — specific peptide blends, proprietary delivery systems (liposomal encapsulation, time-release matrices), unique texture profiles, or clean beauty ingredient restrictions that stock formulas don't accommodate. Full development takes 16–26 weeks, requires R&D fees of $3,000–$15,000+, and typically carries MOQs of 500–1,000 units. The payoff is formula exclusivity (often contractually guaranteed), a technically defensible product story, and the ability to file cosmetic trade secrets or seek patent protection on novel delivery systems.
For most indie founders, the decision framework is simple: if you're pre-revenue or under $50,000 in annual sales, start with a stock formula. If you've validated demand and are pitching retail or raising capital, move to semi-custom. If you're a funded brand with a clear technical differentiation strategy, invest in full custom development.
A common mistake is spending $10,000 on custom development before selling a single unit. The market validation that a stock formula provides is worth far more than the formula exclusivity you gain from custom work — especially when the peptide efficacy story is similar across both routes. AJ Cosmo Labs connects founders with manufacturers offering all three program types, so you can compare options side by side inside the app.
Read the full guide on Private Label Peptide Botox Alternative Cream Manufacturer →